Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.
Savista Acquires ABW Medical, Expanding Ambulatory and Non-Acute Revenue Cycle Management Capabilities
Savista, a healthcare operations company with more than 35 years of revenue cycle management (RCM) experience, today announced the acquisition of ABW Medical, a trusted ambulatory RCM company serving the non-acute healthcare market. The acquisition expands Savista’s footprint into ambulatory and non-acute care segments while giving ABW Medical clients access to Savista’s broader capabilities, infrastructure, and operational scale.
ABW Medical serves an established base of clients, including federally qualified health centers (FQHCs), medical groups, managed service organizations and virtual care providers. ABW also holds preferred RCM partner status within the athenahealth ecosystem, a relationship that strengthens Savista’s position across the ambulatory market and adds further diversity to its EMR expertise.
“ABW Medical brings deep revenue cycle management expertise, a strong client base, and a delivery model that aligns well with how we operate,” said Jan Grimm, Chief Executive Officer at Savista. “This acquisition expands our capabilities and opens new opportunities to serve community and rural health organizations that often face distinct financial pressures. We look forward to deepening that work and helping these organizations achieve the financial sustainability they need to continue serving their communities.”
This acquisition marks a pivotal moment for Savista, strengthening its ability to deliver comprehensive, tailored revenue cycle management solutions to a broader spectrum of healthcare organizations. By addressing the unique needs of community and rural health providers, this expansion aligns seamlessly with Savista’s mission to enhance financial performance and operational efficiency across diverse healthcare settings. The timing is critical as regulatory demands and financial challenges are intensifying, making scalable solutions essential to driving sustainability and supporting long-term growth for clients.
“Joining Savista is an exciting next step for our team and our clients,” said John Bozin, Chief Executive Officer at ABW Medical…
Full release here, originally announced August 27th, 2026.
Cureety Acquires Reimagine Care to Build the Future of Precision Oncology Care
Combination Brings Together Therapy-Specific Precision Monitoring and Clinical Intelligence, AI-Supported Patient Engagement, and Oncology-Specialized Care Teams to Extend More Personalized, Continuous, and Sustainable Cancer Care
Reimagine Care, an AI-powered oncology care organization, today announced that it has been acquired by Cureety, a precision oncology care company. The acquisition brings together Cureety’s therapy-specific monitoring and clinical intelligence with Reimagine Care’s AI-supported patient engagement and oncology-specialized care teams to support more personalized, continuous care beyond the clinic.
Together, Cureety and Reimagine Care form a profitable organization that supports more than 250 cancer centers and 100,000 patients across five countries, with a combined team of approximately 150 people.
The acquisition comes as cancer treatments are becoming increasingly personalized and complex, more care is moving outside the hospital, and oncology teams are supporting growing patient populations with limited clinical resources. Yet care delivery has not evolved at the same pace. The next generation of cancer therapies requires the next generation of cancer care. The combined organization aims to extend the reach of oncology teams beyond scheduled visits, helping them maintain greater visibility between encounters, prioritize patients who need attention, and deliver more personalized, continuous care.
“Cancer is a global challenge, and advances in treatment are creating many of the same opportunities and pressures for oncology teams regardless of where they practice,” said François-Guirec Champoiseau, Co-Founder and CEO at Cureety…
Full release here, originally announced September 2nd, 2026.
No comments:
Post a Comment